A Prevascularized Sinus Tract on the Liver Surface for Islet Transplantation

Background. The lack of a suitable transplantation site has become a bottleneck restricting the development of islet transplantation. Methods. In this study, for the first time, a prevascularized sinus tract (PST) for islet transplantation was constructed in a mouse model by temporarily embedding a 4× silk thread between the liver surface and the attached decellularized human amniotic membrane. After which, the characteristics of the PST and the function of the islet graft within the PST were evaluated. Results. The results showed that PST was lined with granulation tissue, the blood vessel density of the local tissue increased, and proangiogenic proteins were upregulated, which mimics the microenvironment of the islets in the pancreas to a certain extent. Transplantation of ~200 syngeneic islets into the PST routinely reversed the hyperglycemia of the recipient mice and maintained euglycemia for >100 d until the islet grafts were retrieved. The islet grafts within the PST achieved better results to those in the nonprevascularized control groups and comparable results to those under the kidney capsule with respect to glycemic control and glucose tolerance. Conclusions. By attaching a decellularized human amniotic membrane to the surface of mouse liver and temporarily embedding a 4× silk thread, the PST formed on the liver surface has a favorable local microenvironment and is a potential clinical islet transplantation site.

[1]  M. Huising,et al.  Restoring normal islet mass and function in type 1 diabetes through regenerative medicine and tissue engineering. , 2021, The lancet. Diabetes & endocrinology.

[2]  J. Kříž,et al.  The Optimal Maturation of Subcutaneous Pouch Can Improve Pancreatic Islets Engraftment in Rat Model , 2021, Transplantation.

[3]  G. Korbutt,et al.  Conditioning the liver into a favorable niche for pancreatic islet engraftment , 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  G. Korbutt,et al.  Vascularized Stem Cell Derived β-Cell Spheroids: A "Single Step" in the Right Direction for the Treatment of Type 1 Diabetes. , 2021, Transplantation.

[5]  Yasuhiro Nakamura,et al.  The Liver Surface Is an Attractive Transplant Site for Pancreatic Islet Transplantation , 2021, Journal of clinical medicine.

[6]  Bhushan N. Kharbikar,et al.  Modulating the foreign body response of implants for diabetes treatment. , 2021, Advanced drug delivery reviews.

[7]  Dan Wang,et al.  MiR-128-3p Alleviates Spinal Cord Ischemia/Reperfusion Injury Associated Neuroinflammation and Cellular Apoptosis via SP1 Suppression in Rat , 2020, Frontiers in Neuroscience.

[8]  B. Martin,et al.  Human Amniotic Membrane: A review on tissue engineering, application, and storage. , 2020, Journal of biomedical materials research. Part B, Applied biomaterials.

[9]  Jianzhen Lin,et al.  Amniotic Membrane Extract Protects Islets From Serum-Deprivation Induced Impairments and Improves Islet Transplantation Outcome , 2020, Frontiers in Endocrinology.

[10]  M. Bellin,et al.  Transplant strategies for type 1 diabetes: whole pancreas, islet and porcine beta cell therapies , 2020, Diabetologia.

[11]  Song-Cheol Kim,et al.  Evaluation of Multi-Layered Pancreatic Islets and Adipose-Derived Stem Cell Sheets Transplanted on Various Sites for Diabetes Treatment , 2020, Cells.

[12]  Zhaoming Yang,et al.  Comparative Study of Two Different Islet Transplantation Sites in Mice: Hepatic Sinus Tract vs Splenic Parenchyma , 2020, Cell transplantation.

[13]  W. Cui,et al.  Human Amniotic Epithelial Cells and Human Amniotic Membrane as a Vehicle for Islet Cell Transplantation. , 2020, Transplantation proceedings.

[14]  E. O’Cearbhaill,et al.  Vascular endothelial growth factor (VEGF)-releasing microspheres based on poly(ε-caprolactone-PEG-ε-caprolactone)-b-poly(L-lactide) multi-block copolymers incorporated in a 3D-printed poly(dimethylsiloxane) (PDMS) cell macroencapsulation device. , 2019, Journal of pharmaceutical sciences.

[15]  B. Boehm,et al.  Islet macrophages are associated with islet vascular remodeling and compensatory hyperinsulinemia during diabetes. , 2019, American journal of physiology. Endocrinology and metabolism.

[16]  M. Rickels,et al.  Advances in β-cell replacement therapy for the treatment of type 1 diabetes , 2019, The Lancet.

[17]  Wei Song,et al.  Engineering the vasculature for islet transplantation. , 2019, Acta biomaterialia.

[18]  H. Heimberg,et al.  VEGF-A and blood vessels: a beta cell perspective , 2019, Diabetologia.

[19]  W. Hennink,et al.  Vascular Endothelial Growth Factor e Releasing Microspheres Based on Poly( ε -Caprolactone-PEG- ε -Caprolactone)- b -Poly(L-Lactide) Multiblock Copolymers Incorporated in a Three-Dimensional Printed Poly(Dimethylsiloxane) Cell Macroencapsulation Device , 2019 .

[20]  A. Jiao,et al.  Survival and Metabolic Function of Syngeneic Mouse Islet Grafts Transplanted Into the Hepatic Sinus Tract , 2018, Transplantation.

[21]  A. Tomei.  Engineering Confined and Prevascularized Sites for Islet Transplantation. , 2018, Transplantation.

[22]  D. Stamatialis,et al.  An important step towards a prevascularized islet macroencapsulation device—effect of micropatterned membranes on development of endothelial cell network , 2018, Journal of Materials Science: Materials in Medicine.

[23]  Masakazu Yamamoto,et al.  The liver surface as a favorable site for islet cell sheet transplantation in type 1 diabetes model mice , 2018, Regenerative therapy.

[24]  N. Ohuchi,et al.  The Optimization of the Prevascularization Procedures for Improving Subcutaneous Islet Engraftment , 2017, Transplantation.

[25]  A. Powers,et al.  Signals in the pancreatic islet microenvironment influence β‐cell proliferation , 2017, Diabetes, obesity & metabolism.

[26]  W. Hawthorne,et al.  Transplantation sites for porcine islets , 2017, Diabetologia.

[27]  C. Ricordi,et al.  Clinical pancreatic islet transplantation , 2017, Nature Reviews Endocrinology.

[28]  I. Namer,et al.  A Metabolomic Approach (1H HRMAS NMR Spectroscopy) Supported by Histology to Study Early Post-transplantation Responses in Islet-transplanted Livers , 2016, International journal of biological sciences.

[29]  A. Shapiro,et al.  Harnessing the Foreign Body Reaction in Marginal Mass Device-less Subcutaneous Islet Transplantation in Mice , 2016, Transplantation.

[30]  P. Carlsson,et al.  Rapid Restoration of Vascularity and Oxygenation in Mouse and Human Islets Transplanted to Omentum May Contribute to Their Superior Function Compared to Intraportally Transplanted Islets , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[31]  Peng Jia,et al.  Upregulating Hif‐1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound , 2016, Advanced healthcare materials.

[32]  C. Ricordi,et al.  Bioengineering the Endocrine Pancreas: Intraomental Islet Transplantation Within a Biologic Resorbable Scaffold , 2016, Diabetes.

[33]  Tatsuya Kin,et al.  A prevascularized subcutaneous device-less site for islet and cellular transplantation , 2015, Nature Biotechnology.

[34]  A. Seifalian,et al.  Development of a Cost‐Effective and Simple Protocol for Decellularization and Preservation of Human Amniotic Membrane as a Soft Tissue Replacement and Delivery System for Bone Marrow Stromal Cells , 2015, Advanced healthcare materials.

[35]  Y. Rabinowitz,et al.  A Simple Alkaline Method for Decellularizing Human Amniotic Membrane for Cell Culture , 2013, PloS one.

[36]  T. Kieffer,et al.  Implanted islets in the anterior chamber of the eye are prone to autoimmune attack in a mouse model of diabetes , 2013, Diabetologia.

[37]  P. Messersmith,et al.  Biological performance of mussel-inspired adhesive in extrahepatic islet transplantation. , 2010, Biomaterials.

[38]  A. Obenaus,et al.  Factors affecting islet graft embolization in the liver of diabetic mice , 2009, Islets.

[39]  Nathaniel K. Chan,et al.  MRI Assessment of Ischemic Liver After Intraportal Islet Transplantation , 2009, Transplantation.

[40]  Yoshiki Sawa,et al.  Creation of a rich subcutaneous vascular network with implanted adipose tissue-derived stromal cells and adipose tissue enhances subcutaneous grafting of islets in diabetic mice. , 2009, Tissue engineering. Part C, Methods.

[41]  G. Szot,et al.  Transplantation of pancreatic islets into the kidney capsule of diabetic mice. , 2007, Journal of visualized experiments : JoVE.

[42]  M. Hara,et al.  Liver Ischemia Contributes to Early Islet Failure Following Intraportal Transplantation: Benefits of Liver Ischemic‐Preconditioning , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[43]  Y. Tabata,et al.  The Development of New Immunoisolatory Devices Possessing the Ability to Induce Neovascularization , 2003, Cell transplantation.

[44]  E. Ryan,et al.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.

[45]  O. Korsgren,et al.  Isolated Human Islets Trigger an Instant Blood Mediated Inflammatory Reaction: Implications for Intraportal Islet Transplantation as a Treatment for Patients with Type 1 Diabetes , 2000, Upsala journal of medical sciences.